1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Analysis of the US Autoimmune Disease Diagnostics Market 

  • February 2016
  • 59 pages
  • Frost & Sullivan
Report ID: 3691043


Table of Contents

Analysis of the US Autoimmune Disease Diagnostics Market : Systemic Autoimmune Diseases Spur a Double-digit Market Growth Rate of 14.2%

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.

Key Predictions: US Autoimmune Disease Diagnostics Market

Total Autoimmune Disease Diagnostics Market: Key Predictions, US, 2015

The market generated a revenue of $ million in 2015 and is expected to reach $ million in 2020, at a compound annual growth rate (CAGR) of %, spurred by localized diseases, such as celiac, which is expected to grow at % in the United States. Systemic diseases, such as systemic lupus erythematosus (SLE) and RA will remain the highest revenue contributors to the market.

Companies that have multiplexing systems and sensitive nucleic acid amplification technique (NAT)-based assays will be able to meet the need for accurate diagnosis and quick turnaround time when compared to companies that use automation systems like enzymelinked immunosorbent assay (ELISA), which will be reflected in the increasing adoption of NAT-based platforms.

Despite Theranos Inc.’s failure at direct-to-consumer tests, the model still persists in the industry. Gluten allergy tests can be purchased directly by consumers, which will disrupt the lab testing market through test volume revenue loss.

The top market shareholders will expand their revenue by investing in other revenue channels by partnering with pharmaceutical companies for companion diagnostics. Autoimmune diagnostics will no longer be considered a niche market. In vitro diagnostic companies that are established with automation devices will expand their portfolio to cover this market.
An increasing number of platforms will include the genetic analysis component in addition to immunoassays. The accuracy of the results offered by these systems will be increasingly utilized for therapy selection for the personalized treatment of autoimmune disorders.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Ulcerative Colitis Market and Forecast Analysis

  • $ 22000
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Disease Overview Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inappropriate diffuse inflammation of the rectal and colonic mucosa, which occurs in the innermost laye ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Epiomic Epidemiology Series: Ankylosing Spondylitis Forecast in 13 Major Markets 2017-2027

  • $ 5112
  • Industry report
  • March 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ankylosing Spondylitis in 13 Major Markets Ankylosing Spondylitis (AkS) is a chronic, systemic inflammatory autoimmune disease. It ...

Download Unlimited Documents from Trusted Public Sources

Diabetes Statistics in China

  • May 2017
    13 pages
  • Diabetes  

  • China  

View report >

Cardiovascular Disease Statistics in Sweden

  • May 2017
    9 pages
  • Cardiovascular ...  

  • Sweden  


View report >

Infectious Disease Statistics

  • May 2017
    172 pages
  • Infectious Dise...  


  • United States  


    North America  

View report >

Related Market Segments :

Autoimmune Disease


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.